Form 4 for RMD ResMed|
Accepted 2022-02-04 00:00:00 ET · period of report 2022-02-03 · accession 0001127602-22-003444 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-02-04 | 2022-02-03 | RMD | PENDARVIS DAVID | Chief Administration Off | S - Sale | $232.87 | -1,544 | 114.5K | -1% | -$359.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | ResMed Common Stock | 2022-02-03 | S | D | 1,544 | $232.87 | 114,491 | D | — | — |